A detailed history of Criterion Capital Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Criterion Capital Advisors, LLC holds 59 shares of AZN stock, worth $3,911. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59
Previous 59 -0.0%
Holding current value
$3,911
Previous $4.6 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$61.89 - $69.28 $3,651 - $4,087
59 New
59 $3.97 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Criterion Capital Advisors, LLC Portfolio

Follow Criterion Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Criterion Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Criterion Capital Advisors, LLC with notifications on news.